Deciding on the appropriate pharmacotherapy for the treatment of endometriosis

Carneiro MM; Márcia Mendonça Carneiro

doi:10.1080/14656566.2022.2113383

Deciding on the appropriate pharmacotherapy for the treatment of endometriosis

Carneiro MM, Márcia Mendonça Carneiro

Expert opinion on pharmacotherapy · 2022 · vol. 24(1) , pp. 1–5 · doi:10.1080/14656566.2022.2113383 · PMID:35973977 · W4292170665

Other OA: closed CC0 ⤵ 16 in-corpus citations

📄 Open PDF View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This review discusses current pharmacotherapy options for endometriosis, examining their efficacy and side effect profiles to guide treatment decisions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (21)

Assessing research gaps and unmet needs in endometriosis via openalex
Diagnosis and management of endometriosis: summary of NICE guidance via openalex
Elagolix for endometriosis: all that glitters is not gold via openalex
Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis via openalex
Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial via openalex
Hormonal contraception in women with endometriosis: a systematic review via openalex
Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis via openalex
New developments in the medical treatment of endometriosis via openalex
New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments via openalex
Pathogenesis of Endometriosis: New Insights into Prospective Therapies via openalex
Pathogenesis of Endometriosis: The Origin of Pain and Subfertility via openalex
Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis via openalex
Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study via openalex
Reevaluating response and failure of medical treatment of endometriosis: a systematic review via openalex
Rethinking mechanisms, diagnosis and management of endometriosis via openalex
Treatment of endometriosis: a review with comparison of 8 guidelines via openalex
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex
Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence via openalex
W3194419458 via openalex
W3119380823 via openalex

Cited by (16)

Source provenance

europepmc: last seen: 2026-10-15T06:08:49.021275+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-10-08T21:36:27.764070+00:00
unpaywall: last seen: 2026-09-18T06:25:56.777850+00:00

License: CC0 · commercial use OK

[1] Assessing research gaps and unmet needs in endometriosis via openalex

[2] Diagnosis and management of endometriosis: summary of NICE guidance via openalex

[3] Elagolix for endometriosis: all that glitters is not gold via openalex

[4] Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis via openalex

[5] Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial via openalex

[6] Hormonal contraception in women with endometriosis: a systematic review via openalex

[7] Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis via openalex

[8] New developments in the medical treatment of endometriosis via openalex

[9] New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments via openalex

[10] Pathogenesis of Endometriosis: New Insights into Prospective Therapies via openalex

[11] Pathogenesis of Endometriosis: The Origin of Pain and Subfertility via openalex

[12] Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis via openalex

[13] Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study via openalex

[14] Reevaluating response and failure of medical treatment of endometriosis: a systematic review via openalex

[15] Rethinking mechanisms, diagnosis and management of endometriosis via openalex

[16] Treatment of endometriosis: a review with comparison of 8 guidelines via openalex

[17] Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex

[18] Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex

[19] Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence via openalex

[20] W3194419458 via openalex

[21] W3119380823 via openalex